USZ BioResource COVID-19

Terminated

• Conditions: COVID19

• Registration Number: NCT04414657
• Lead Sponsor: Regina Grossmann

Brief Summary

Mono-centric. Blood sampling for biobank development, including linkage to patient data (resource for research on COVID19).

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-09
• Study First Submitted: 2020-06-02
• Study First Submitted QC: 2020-06-02
• Study First Posted: 2020-06-04
• Primary Completion: 2021-09-30
• Study Completion: 2021-09-30
• Status Verified: 2022-11
• Last Update Submitted: 2022-11-07
• Last Update Posted: 2022-11-14

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• m/f age > 18 years
• SARS-CoV-2 infektion (according to WHO guideline)
• hospitalisation, general ward
• acceptable language knowledge
• voluntary IFC and biobank appendix

Exclusion Criteria

• contra indication for blood sampling

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
blood sampling for biobank	2 years	development of a biobank

Trial Locations

Locations (1)

University Hospital Zurich, Clinical Trials Center; 🇨🇭 Zurich, Switzerland